Navigate Related Headlines
MAGIC IN THE BRAIN: WHERE SCIENCE AND SPIRITUALITY MEET
NAVIGESIA CEO, Dr. Ketan Patel is joined by Ben Medrano, Shannon Smadella and Dr Joe Tafur to discuss..... at the first ever World Psychedelics Day
NAVIGESIA: Personalized Medicine Data Platform for Clinical Neurosciences and Emerging Therapeutics (Cannabis, Psychedelics, Nootropics)
NAVIGESIA, a personalized medicine software company expands their real-world data tools for clinical neurology and psychology industries, supporting patient management with psychoactive compounds: cannabis, psychedelics, nootropics.
Gwella Launches Mushroom-Focused Brand House & Closes Financing
Gwella Mushrooms Inc. ("Gwella"), recently announced their launch as a life sciences company and brand house with a focus on adaptogenic, medicinal and psychedelic mushrooms. Gwella is capitalizing on one of the most exciting trends of 2020: the emergence of the functional mushroom market; which is estimated to be a $30B (CAD) market, globally. The trend is generating substantial traction due to the shift in consumer demand for organic healthy foods and alternative therapies.